Snowball logo
logo
VVY_logo

Vivoryon Therapeutics NV

VVY β€’ AS
€1.125-€0.015Β  (1.32%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
10.76-(3.62)---
COGS
1.7340.161(0.525)0.1470.1470.288
Gross Profit
9.03(0.161)(3.095)(0.147)(0.147)(0.288)
Operating Expenses & Income
Operating Income
(12.81)(29.13)(28.84)(20.96)(9.177)(19.72)
Total Operating Expenses
21.8428.9725.7420.819.0319.5
R&D Expenses
17.4520.2217.6414.064.3819.79
Selling General & Admin Expenses
0.0045498.9053.2726.92.586.154
Earnings from Continuing Operations
Interest Expense
(0.024)(0.024)(0.056)(0.086)(0.045)(0.133)
Interest Income
0.0210.0420.4780.4260.106-
Income Tax Expense
0.432(0.199)(0.234)---
Net Income
Net Income
(12.65)(28.16)(28.34)(20.57)(8.853)(19.25)
Supplemental
EBIT
(12.2)(28.33)(28.52)(20.48)(9.177)(19.5)
EBITDA
(12.03)(28.17)(28.35)(20.34)(9.03)(19.24)
In millions of EUR, except % and values per 1 share